The Congenital Adrenal Hyperplasia Market Technology is driven by advanced diagnostics, AI-assisted hormone analysis, prenatal testing, and innovative enzyme replacement therapies. High-sensitivity assays, tandem mass spectrometry, and non-invasive prenatal diagnostics are transforming early detection and patient management. Integration with hospital information systems, predictive analytics,...